- Home
- Tenders
- Germany
- Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Betahistin (N07CA01) im Rahmen eines sogenannten Open-House-Modells
Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Betahistin (N07CA01) im Rahmen eines sogenannten Open-House-Modells
Description
AOK Rheinland-Pfalz/Saarland seeks to establish non-exclusive discount contracts for medicinal products containing the active ingredient betahistin (N07CA01). These products are intended for the treat**** ** ********** **** ** ******* *** ************* *********** ***** ***** ********* **** ****** ** ******** **** *** * **** *** ** *** ****** ****** **** *** ********* ****** ********* **** ** *** ******* ***** ** ********* ********** ****** ******** ********* ** **** ** ***** *** ********* ****** *** ********* ****** ****** ** **** * ***** ** ****** *** ***** ********** ******** ****** *** ******** *** ******** **** **** *********** ***** ** *** ***** **** *** * ** ********* ** *** ** *** ***** ** *********** *** ***** ********* ** ******************** ********** *** **
Want to unlock the full information?
Member-only information. Become a member to access this information.
Procurement notices from more than 200 sources and banks are available here
Details
Status:
Open
Sectors:
33600000 - Pharmaceutical products
Place of origin:
Germany
Places of performance:
Germany
Deadline:
Dec 31, 2025
Contract type:
Member-only information
Publication date:
Member-only information
Update date:
Member-only information
Stored documents
Member-only information
Original URL:
Member-only information
Buyers
Member-only information